José Presa (@jospresa3) 's Twitter Profile
José Presa

@jospresa3

Head of Liver Unit. CHTMAD
Vila Real
Portugal

ID: 1009380387498463233

calendar_today20-06-2018 10:20:12

3,3K Tweet

1,1K Followers

1,1K Following

Sahaj Rathi MD, DM, MRCP (@sahajrathi) 's Twitter Profile Photo

#APASL guidelines on management of acute variceal bleeding are out🚨 Glad to have participated in drafting the section on “Role of endoscopy in AVB” Special thanks to Prof Shiv Sarin for the opportunity, Prof #RinaldiLesmana for the excellent leadership, and kudos to the

#APASL guidelines on management of acute variceal bleeding are out🚨

Glad to have participated in drafting the section on “Role of endoscopy in AVB”

Special thanks to Prof <a href="/drshivsarin/">Shiv Sarin</a> for the opportunity, Prof #RinaldiLesmana for the excellent leadership, and kudos to the
Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

Lenvatinib in patients with advanced HCC after first-line atezo/ beva Journal of Hepatology doi.org/10.1016/j.jhep… 🔎50 pts🇰🇷, phs II 👉ORR: 14% 👉mPFS: 5.4 mo 👉mOS: 9.8 mo 🧐All TKI somewhat effective after ICI 1st line, no clear winner so far ESMO - Eur. Oncology EASL Education ILCA

Lenvatinib in patients with advanced HCC after first-line atezo/ beva
<a href="/JHepatology/">Journal of Hepatology</a> 
doi.org/10.1016/j.jhep…
🔎50 pts🇰🇷, phs II
👉ORR: 14%
👉mPFS: 5.4 mo
👉mOS: 9.8 mo
🧐All TKI somewhat effective after ICI 1st line, no clear winner so far
<a href="/myESMO/">ESMO - Eur. Oncology</a> <a href="/EASLedu/">EASL Education</a> <a href="/ILCAnews/">ILCA</a>
Thomas Reiberger (@reibergerthomas) 's Twitter Profile Photo

Jaime Bosch - The Lancet thelancet.com/journals/lance… I recognize Jaume in every single word of this article - he congratulated me as a young fellow on our Vienna Liver News Carvedilol primary bleeding prophylaxis study Very thankful for our The Baveno Cooperation: an EASL Consortium journey for many years.

JHEP Reports (@jhep_reports) 's Twitter Profile Photo

🟣Comparative risk of osteoporosis and fractures in chronic hepatitis B patients: Tenofovir disoproxil fumarate vs. entecavir in a Korean nationwide cohort 🔓#OpenAccess at 👉 jhep-reports.eu/article/S2589-… #LiverTwitter #LiverX #HBV

🟣Comparative risk of osteoporosis and fractures in chronic hepatitis B patients: Tenofovir disoproxil fumarate vs. entecavir in a Korean nationwide cohort

🔓#OpenAccess at 👉 jhep-reports.eu/article/S2589-…

#LiverTwitter
#LiverX
#HBV
Javier Crespo (@drjaviercrespo) 's Twitter Profile Photo

Valdecilla abre nuevas vías de tratamiento de la cirrosis y la hipertensión portal, dos de las complicaciones más graves de la enfermedad hepática humv.es/2025/10/08/val…

Ramon Bataller (@rabataller) 's Twitter Profile Photo

Honored to speak today in Porto invited by my friend José Presa about controversies in MASLD and MetALD terminology. Here is a preview slide and the 5 main controversies. SLD meetings emphasize MASLD, talk about MetALD, while ALD gets little attention. This imbalance matters.

Honored to speak today in Porto invited by my friend <a href="/JosPresa3/">José Presa</a> about controversies in MASLD and MetALD terminology.

Here is a preview slide and the 5 main controversies.

SLD meetings emphasize MASLD, talk about MetALD, while ALD gets little attention. This imbalance matters.
Javier Crespo (@drjaviercrespo) 's Twitter Profile Photo

Without urgent prevention, screening, and policy interventions, the growing MASH burden will escalate clinical, economic, and quality-of-life consequences, underscoring the need for timely action at national and global levels. Sociedad Española de Patología Digestiva (SEPD) Asociación Española para el Estudio del Hígado AASLD EASLnews

Without urgent prevention, screening, and policy
interventions, the growing MASH burden will escalate
clinical, economic, and quality-of-life consequences,
underscoring the need for timely action at
national and global levels.
<a href="/sepdigestiva/">Sociedad Española de Patología Digestiva (SEPD)</a> <a href="/AEEHLiver/">Asociación Española para el Estudio del Hígado</a> <a href="/AASLDtweets/">AASLD</a> <a href="/EASLnews/">EASLnews</a>
Akash Roy (@royahep) 's Twitter Profile Photo

📜Just published in JCEH! Stool urease activity (SUA) better predicts OHE than NH3 📈 SUA linked to gut 🦠 activity & hyperammonemia. 🧫 ?novel biomarker for early OHE risk ILBS_University Shiv Sarin Dr Nipun Verma Anand V Kulkarni Shalimar Rahul Kumar jcehepatology.com/article/S0973-…

Mattias Mandorfer (@mattiasmandorf1) 's Twitter Profile Photo

😀🇦🇹 multisociety (gastroenterology & hepatology, diabetology & obesity) consensus on MASLD (& MetALD!) 🤝Well-aligned with EASLnews CPGs 😟Reimbursement currently restricted to semaglutide for T2DM 🤔Reimbursement in our country? 🖇️: rdcu.be/eLAde #LiverTwitter

😀🇦🇹 multisociety (gastroenterology &amp; hepatology, diabetology &amp; obesity) consensus on MASLD (&amp; MetALD!)
🤝Well-aligned with <a href="/EASLnews/">EASLnews</a> CPGs
😟Reimbursement currently restricted to semaglutide for T2DM
🤔Reimbursement in our country?

🖇️: rdcu.be/eLAde

#LiverTwitter
Alessandro Vitale (@vaital73) 's Twitter Profile Photo

🚨 Just published in The Lancet and presented at #ESMO25! 👉 The CARES-009 trial is the first Phase III study showing that perioperative (neoadjuvant + adjuvant) camrelizumab + rivoceranib significantly improves event-free survival (EFS 42.1 vs 19.4 mo; HR 0.59, p=0.004) vs

🚨 Just published in The Lancet and presented at #ESMO25!

👉 The CARES-009 trial is the first Phase III study showing that perioperative (neoadjuvant + adjuvant) camrelizumab + rivoceranib significantly improves event-free survival (EFS 42.1 vs 19.4 mo; HR 0.59, p=0.004) vs
Akash Roy (@royahep) 's Twitter Profile Photo

New Journal of Clinical and Experimental Hepatology Dr Kaushal Madan Dr Ashish Kumar 📘 Biopsy in HCC: Time to rethink the needle? Imaging often suffices but not always 🔹 💉 enables molecular profiling 🔹 ⚠️ 🩸, seeding, sampling error 🔹 Future: liquid biopsy 💧 + radiomics 👇🏽 jcehepatology.com/article/S0973-…

Alan Bonder (@bonderalan) 's Twitter Profile Photo

💚 Today we celebrate PSC Awareness Day! Let’s come together to raise awareness, share knowledge, and push for research that leads to better treatments — and one day, a cure for Primary Sclerosing Cholangitis. #PSCAwarenessDay #LiverHealth #CurePSC

Ramon Bataller (@rabataller) 's Twitter Profile Photo

Liver fellows should be trained in MOTIVATIONAL INTERVIEWING. My main 5 practical advice: 1️⃣ Show them that you care 2️⃣ Avoid judging or lecturing 3️⃣ Set realistic goals together 4️⃣ Celebrate small steps 5️⃣ Stay kind, even if they aren’t ready

Liver fellows should be trained in MOTIVATIONAL INTERVIEWING. My main 5 practical advice:

1️⃣ Show them that you care
2️⃣ Avoid judging or lecturing
3️⃣ Set realistic goals together
4️⃣ Celebrate small steps
5️⃣ Stay kind, even if they aren’t ready
Ramon Bataller (@rabataller) 's Twitter Profile Photo

New insights on assessing LIVER FIBROSIS with NON-INVASIVE TESTS, just released by NEJM: - Key techniques & thresholds. - Practical algorithms & actionable steps. shorturl.at/amz1p

New insights on assessing LIVER FIBROSIS with NON-INVASIVE TESTS, just released by <a href="/NEJM/">NEJM</a>:

- Key techniques &amp; thresholds.
- Practical algorithms &amp; actionable steps.
shorturl.at/amz1p